Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maze Therapeutics (MAZE) Treasury Shares (2024 - 2025)

Maze Therapeutics has reported Treasury Shares over the past 2 years, most recently at $10372.0 for Q4 2025.

  • Quarterly Treasury Shares changed 0.0% to $10372.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $10372.0 through Dec 2025, changed 0.0% year-over-year, with the annual reading at $10372.0 for FY2025, 0.0% changed from the prior year.
  • Treasury Shares was $10372.0 for Q4 2025 at Maze Therapeutics, down from $594825.0 in the prior quarter.
  • Over five years, Treasury Shares peaked at $594825.0 in Q3 2025 and troughed at $10372.0 in Q4 2024.